SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-000903
Filing Date
2017-01-05
Accepted
2017-01-05 16:01:26
Documents
5
Period of Report
2017-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-1272_38k.htm 8-K 42364
2 EX-1.1 a17-1272_3ex1d1.htm EX-1.1 194826
3 EX-5.1 a17-1272_3ex5d1.htm EX-5.1 22241
4 EX-99.1 a17-1272_3ex99d1.htm EX-99.1 12794
5 GRAPHIC g12723kki001.jpg GRAPHIC 6448
  Complete submission text file 0001104659-17-000903.txt   282455
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 17510568
SIC: 2834 Pharmaceutical Preparations